应用预防医学
應用預防醫學
응용예방의학
JOURNAL OF APPLIED PREVENTIVE MEDICINE
2013年
4期
193-198
,共6页
吴健林%吴继周%韦颖华%庞裕%李红玉
吳健林%吳繼週%韋穎華%龐裕%李紅玉
오건림%오계주%위영화%방유%리홍옥
HLA-DRB1%等位基因%基因频率%原发性肝癌%家庭聚集性
HLA-DRB1%等位基因%基因頻率%原髮性肝癌%傢庭聚集性
HLA-DRB1%등위기인%기인빈솔%원발성간암%가정취집성
HLA-DRB1%Allele%Gene frequency%Hepatocellular carcinoma%Familial aggregation
目的探讨人类白细胞相关抗原复合体的DRB1*07/09/11等位基因对广西肝癌高发区肝癌家族聚集性的影响。方法以配对方法选取广西肝癌高发区的肝癌高发家族成员、肝癌单发家族成员及无癌家族成员各153例作为研究对象,应用聚合酶链反应/序列特异性引物(PCR-SSP)方法检测HLA-DRB1*07/09/11等位基因,统计分析各等位基因与原发性肝癌家庭聚集性的相关性。结果(1) HLA-DRB1*07/09等位基因在肝癌高发家族成员组、肝癌单发家族成员组和无癌家族成员组的基因频率分别为0.70%和2.00%、2.60%和19.00%、23.50%和16.30%(P>0.05);HLA-DRB1*11为2.60%、13.70%和11.10%(P<0.01);(2) HLA-DRB1*07/09/11等位基因在乙型肝炎病毒感染成员组(HBsAg阳性组)及非乙肝病毒感染成员组(HBsAg阴性组)中的基因频率分别为:0%、2.60%;19.00%、19.90%和9.50%、9.00%(P值均>0.05)。结论(1) HLA-DRB1*11等位基因可能是广西肝癌高发区原发性肝癌发生的拮抗基因,其缺失可能是导致广西肝癌高发区肝癌家族聚集性原因之一。(2)HLA-DRB1*07、09、11等位基因与广西肝癌高发区乙肝病毒感染的易感性似无明显关联。
目的探討人類白細胞相關抗原複閤體的DRB1*07/09/11等位基因對廣西肝癌高髮區肝癌傢族聚集性的影響。方法以配對方法選取廣西肝癌高髮區的肝癌高髮傢族成員、肝癌單髮傢族成員及無癌傢族成員各153例作為研究對象,應用聚閤酶鏈反應/序列特異性引物(PCR-SSP)方法檢測HLA-DRB1*07/09/11等位基因,統計分析各等位基因與原髮性肝癌傢庭聚集性的相關性。結果(1) HLA-DRB1*07/09等位基因在肝癌高髮傢族成員組、肝癌單髮傢族成員組和無癌傢族成員組的基因頻率分彆為0.70%和2.00%、2.60%和19.00%、23.50%和16.30%(P>0.05);HLA-DRB1*11為2.60%、13.70%和11.10%(P<0.01);(2) HLA-DRB1*07/09/11等位基因在乙型肝炎病毒感染成員組(HBsAg暘性組)及非乙肝病毒感染成員組(HBsAg陰性組)中的基因頻率分彆為:0%、2.60%;19.00%、19.90%和9.50%、9.00%(P值均>0.05)。結論(1) HLA-DRB1*11等位基因可能是廣西肝癌高髮區原髮性肝癌髮生的拮抗基因,其缺失可能是導緻廣西肝癌高髮區肝癌傢族聚集性原因之一。(2)HLA-DRB1*07、09、11等位基因與廣西肝癌高髮區乙肝病毒感染的易感性似無明顯關聯。
목적탐토인류백세포상관항원복합체적DRB1*07/09/11등위기인대엄서간암고발구간암가족취집성적영향。방법이배대방법선취엄서간암고발구적간암고발가족성원、간암단발가족성원급무암가족성원각153례작위연구대상,응용취합매련반응/서렬특이성인물(PCR-SSP)방법검측HLA-DRB1*07/09/11등위기인,통계분석각등위기인여원발성간암가정취집성적상관성。결과(1) HLA-DRB1*07/09등위기인재간암고발가족성원조、간암단발가족성원조화무암가족성원조적기인빈솔분별위0.70%화2.00%、2.60%화19.00%、23.50%화16.30%(P>0.05);HLA-DRB1*11위2.60%、13.70%화11.10%(P<0.01);(2) HLA-DRB1*07/09/11등위기인재을형간염병독감염성원조(HBsAg양성조)급비을간병독감염성원조(HBsAg음성조)중적기인빈솔분별위:0%、2.60%;19.00%、19.90%화9.50%、9.00%(P치균>0.05)。결론(1) HLA-DRB1*11등위기인가능시엄서간암고발구원발성간암발생적길항기인,기결실가능시도치엄서간암고발구간암가족취집성원인지일。(2)HLA-DRB1*07、09、11등위기인여엄서간암고발구을간병독감염적역감성사무명현관련。
Objective To study the effect of HLA-DRB1*07/09/11 alleles on familial aggregation of hepatocellular carcinoma(HCC) in high hepatocellular carcinoma incidence area of Guangxi. Methods 153 family members from those families which have had two or more than two patients with hepatocellular carcinoma(FHHC group), 153 from those families which have had only one patient with hepatocellular carcinoma(FOHC group) and 153 from those families which have had none carcinoma patients(FNC group) were selected and matched as study object in the high hepatocellular carcinoma incidence areas of Guangxi. Polymerase chain reaction using sequence specific primer (PCR-SSP) was employed to tested HLA-DRB1*07, HLA-DRB1*09, HLA-DRB1*11 alleles;the correlation bewteen HLA-DRB1*07/09/11 alleles and familial aggregation of HCC in the high hepatocellular carcinoma incidence areas of Guangxi was analysed by statistical methods. Results (1) The gene frequency of allele HLA-DRB1*07 in the FHHC group,FOHC group and FNC group was 0.7%,2.0%and 2.6%(P>0.05) respectively;HLA-DRB1*09 was 19.00%, 23.50%and 16.30%(P>0.05);HLA-DRB1*11 was 2.60%,13.70%and 11.10%(P<0.01).(2) The gene frequency of HLA-DRB1*07,09 and 11 alleles in HBsAg postive group and HBsAg negative group was respectively:HLA-DRB1*07 was 0% and 2.60%(??2=1.70, P>0.05); HLA-DRB1*09 was 19.0% and 19.9%(??2=0.04, P>0.05);HLA-DRB1*11 was 9.50%and 9.00%(??2=0.04, P>0.05). Conclusions (1)HLA-DRB1*11 seems to be the antagonist genes of hepatocellular carcinoma in high HCC incidence areas of Guangxi, and the gene deletion may be the cause of leading to the familial aggregation of hepatocellular carcinoma in high HCC incidence areas of Guangxi. (2) There may be not significant correlation bewteen HLA-DRB1*07, 09,and 11 alleles and the susceptibility of HBV infection in high HCC incidence area of Guangxi.